Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |